Longevity Diagnostics
Continuous Glucose Monitoring for Non-Diabetics: Worth It?
What changed
Why CGMs Are Suddenly Everywhere
In 2024 the FDA cleared the first over-the-counter CGMs for non-diabetic adults — Dexcom Stelo and Abbott Lingo. Levels, Nutrisense, Signos, and Ultrahuman layer coaching software on top of those same sensors.
A sensor lasts 14–15 days. It sits on the back of the upper arm, reads interstitial glucose every minute, and streams data to a phone app.
The promise: see how specific meals, sleep, stress, and workouts move your glucose — and use that feedback to make better choices.
What's real
What CGMs Can Actually Teach a Healthy Adult
Real and useful: postprandial glucose responses are highly individual. Two people eating the same oatmeal can spike very differently. CGMs surface those differences in days, which would otherwise require weeks of finger-stick testing.
Behavior change is the proven mechanism: in studies of non-diabetics, wearing a CGM for 2–8 weeks tends to reduce sugar-sweetened beverage intake, improve meal sequencing (fiber/protein before refined carbs), and prompt post-meal walks.
What's overstated: glucose 'variability' as a longevity metric in already-healthy adults. Non-diabetic adults will show spikes from white rice, juice, and processed carbs — that doesn't mean they're prediabetic; it means they're human.
Where it falls short
Where the Hype Outruns the Evidence
There is no good outcome data showing that chronic CGM use in metabolically healthy adults reduces cardiovascular events, slows aging, or improves any hard endpoint beyond what the same person would achieve by losing visceral fat, resistance training, and eating fewer refined carbs.
Interstitial glucose lags blood glucose by 5–15 minutes; sensor noise is real, and dramatic-looking spikes are sometimes artifact. Treating every spike as a problem to fix can drift into orthorexic behavior.
Many app-driven 'glucose scores' use proprietary algorithms with no validation against clinical endpoints.
Cost
What CGM Programs Cost in 2026
- ·Dexcom Stelo (OTC): $99 for two sensors (~28 days). No app subscription required.
- ·Abbott Lingo (OTC): $89/month for two sensors with coaching app.
- ·Levels: $199/month including sensors and coaching.
- ·Nutrisense: $225/month with dietitian support.
- ·Signos: $159/month bundled with sensors.
Insurance does not cover non-diabetic CGM use. HSA/FSA reimbursement is sometimes available with a physician letter of medical necessity.
Pricing reviewed June 2026.
Who benefits
Who Should Actually Try a CGM
Strong candidates: anyone with prediabetes (HbA1c 5.7–6.4), a family history of type 2 diabetes, GLP-1 patients exploring food responses, or a motivated adult who will use 2–4 weeks of data to change behavior and then stop.
Weaker case: a metabolically healthy adult planning to wear one indefinitely as a longevity score. Spend the same money on a coronary calcium scan, ApoB panel, and a VO2 max test first.
Frequently asked
Common questions
Do I need a prescription for a CGM?
No. Stelo and Lingo are FDA-cleared OTC for adults without diabetes. Levels, Nutrisense, and Signos bundle the sensors with software.
How much does a CGM cost per month?
Roughly $89–$225/month depending on whether you want raw sensors only or coaching software. Insurance does not cover non-diabetic use.
Are post-meal glucose spikes dangerous?
In a healthy adult, postprandial spikes into the 140–180 mg/dL range are physiologic and not by themselves harmful. Persistent fasting glucose over 100 or HbA1c trending up matters more.
Will a CGM help me lose weight?
Indirectly, by surfacing the carbs and snacks that drive your personal spikes — leading many users to change behavior. There is no metabolic magic in CGM data itself.
How long should I wear a CGM?
For most non-diabetic adults, 2–8 weeks is enough to learn your personal responses. Indefinite wear adds cost without proven outcome benefit.
References
Sources
- 1.FDA Clears First Over-the-Counter Continuous Glucose Monitor — U.S. Food and Drug Administration, 2024.
- 2.Personalized Nutrition by Prediction of Glycemic Responses — Cell, 2015.
- 3.Continuous Glucose Monitoring in People Without Diabetes — Review — Diabetes Technology & Therapeutics, 2023.
Related